The relationship of the rehabilitation and the behavioral medicine;Vzt'ah rehabilitácie a behaviorálnej medicíny

Eurorehab

Volumn , Issue 3, 2002, Pages 139-145

  Takac P ^a  

^a Vysokospec Odb U stav Geriatr   (Slovakia)

Author keywords

Behavior; Behavioral medicine; Bio behavioral mechanism; Bio psycho social model; Comprehensive rehabilitation; Life style; Primary prevention

Indexed keywords

ARTICLE; ATTITUDE; BEHAVIORAL MEDICINE; DEMOGRAPHY; EPIDEMIOLOGICAL DATA; HISTORY OF MEDICINE; LIFESTYLE; MORBIDITY; MORTALITY; PATHOGENESIS; PATIENT CARE; QUALITY OF LIFE; REHABILITATION MEDICINE;

EID: 2042460829     PISSN: 12100366     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Baštecký, J., Kukleta, M.: Současný stav a perspektivy behaviorální medicíny. In: Psychosomatika/Behaviorální Medicína Dnes. Sborník Krátkych Verzí Přednesených Přednášek na IX. Česko-Slovenskó Konferenci Psychosomatické a Behavíorální Mediciny v Plzni ve Dnech 24. - 26. Září 1998, Galén, Praha 1998, s. 11-13)
2. Cagáň, S., Pavlovič, M., Besedová I.: Poznámky k epidemiológii a prevencii kardiovaskulárnych chorôb po roku 1989. Bratisl. Lek. Listy 100, 1999, č. 7, s. 395-404
3. Collective Name: EUROASPIRE II Study Group: Lifestyle and risk factor management and use of druh therapies ín coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur. Heart J., 22, 2001, 7, p. 554-72
4. Egnerová, A., Cagáň, S.: Úmrtnost' na ischemickú chorobu srdca na Slovensku v rokoch 1971 až 1980. Lek. Obzor, 35, 1986, 11, s. 609-615
5. Elisaf, M.: The treatment of coronary heart disease: An update: Part 1: An oerwiew of the risk factors for cardíovascular disease. Curr. Med. Res. Opin., 17 (1), 2001, p. 18-26
6. Ginter, E.: Prevencia kardiovaskulárnych ochorení: Fínska skúsenost' a súčasnost'. Bratisl. Lek. Listy, 98, 1997, 2, s. 67-72
7. Ginter, E.: Vývoj včasnej kardiovaskulárnej mortality v strednej Európe v poslednom desat'ročí. Cardiol., 7, 1998, 3, s. 119-122
8. Goldman, L., Cook, E. F.: The decline in ischemíc heart disease mortality rates. Analysis of the comparative effects of medical interventíons and changes in lifestyle. Ann. Inter. Med., 101, 1984, 6, s. 825-836
9. Gordon, N., F., Comprehensive Cardiovascular Disease Risk Management in Clinical an Community-based Settings. [online], American College of Sportsmedicine, A Newsletter for Certified Clinical and Health & Fitness Professionals, Vol. 8, No 3, 1998, [cit. 25-06-2002], available on: http://www.interventusa.com/news_art2_1.html
10. Hu, F.,B., Stampfler, M., J., Manson, J., E., et al.: Trends in the incidence of coronary herat disease and changes in diet and lifestyle in women. N. Engl. J. Med, 343, 2000, 8, p. 530-7
11. st Century. [online], Intervent USA, Lifestyle Management & Cardiovascular Risk Reduction Programs. [cit. 2506-2002] Available on: http://www.interventusa.com/products_cr.html
12. Karjaleinen, K.,Malmivaara, A., van Tulder, M., et al.: Mulitidisciplinary biopsychosocial rehabilitation for subacute low back pain in working-age adults: A systematic rewiew within teh framework of the Cochrane Collaboration back rewiew group. Spine, 2001, 26 (3), s. 262-269.
13. Kopp, M.: Psychosocial risk factors, inequality and self-rated morbidity in a changing society. Lecture. Increase in Coronary Heart Disease in the Central and Eastern Europe: Stress and Gender Related Factors - NATO Advanced Research Workshop, May 20 - 24, 2000, Budapest
14. Kristenson, M.: Chronic stress and the rising CHD in Eastern Europe: Results from a comparative study od Sweden and Lithuania. Lecture. Increase in Coronary Heart Disease in the Central and Eastern Europe: Stress and Gender Related Factors - NATO Advanced Research Workshop, May 20 - 24, 2000, Budapest
15. Malý, M.: Minulost' a súčasnost' rehabilitačnej medicíny. Eurorehab., 4, 1992, s. 179-180
16. Omísh, D., Brown, S., E., Sherwitz, L.W. et al.: Can lifestyle changes reverse coronary heart disease? Lancet, 336, 1990, p. 129-133.
17. Ornish, D.: Avoiding revascularization with lifestyle changes. The Multicenter Lifestyle Demonstration Project. Am. J. Cardiol., 82 (10B), 1998, p. 72T-76T
18. Panagiotakos, D., B., Pitsavos, C., Chrysohoou, C., et al.: Risk stratification of coronary hert disease through estabilished and emerging lifestyle factors in a Mediterranean population: CARDIO2000 epídemiological study. J. Cardiovasc. Risk, 8, 2001, 6, p. 329-35
19. Palát, M.: Súčasnost' a perspektíva rehabílitačnej medicíny. Eurorehab, V, 1995, 1, s. 3-4
20. Peek, P., M., Womble, L. G.: Lifestyle and Behavior Modification in the Management of Obesity, CME, [online], Release date April 11, 2001, [cit. 13-6-2002], available on: http://www.medscape.com/viewprogram/710_pnt
21. Pfeiffer, J.: Systėm moderní rehabilitace. In.:Trojan, S. a kol.: Fyziologie a Léčebná Rehabilitace Motoriky Člověka. 2. Vyd. Grada, Praha 2001, s. 195-218
22. Rutledge, T., et al.: Psychosocial variables are associated with atherosclerosis risc factors among women with chest pain: The Wise Study. Psychosom. Med. 2001, 63, p. 282-288
23. Shapiro, D., Hiu, K.,K., Oakley, M.,E., et al.: Reduction in drug requirements for hypertension by means of a cognitive-behavioral intervention. Am. J. Hypertens., 1997, 10 (1), p. 9-17
24. Skorodenský, M.: Biobehaviorálne rizikové faktory ICHS. In: Psychosomatika/Behaviorální medicina dnes. Sborník krátkych verzí přednesených přednášek na IX. Česko-slovenské konferenci psychosomatické a behaviorální mediciny v PIzni ve dnech 24. - 26. září 1998, Galén, Praha 1998, s. 68-69
25. Skorodenskẏ, M.: Psychologické a behaviorálne liečebnė postupy pre choroby srdca a ciev. In.: Skorodenský, M.: Psychologické Rizikové Faktory Ischemickej Choroby Srdca. Veda SAV, Bratislava 1991, s. 147-163
26. Spiegel, D., Bloom, R., Kraemer, H.C. et al.: Effect of psychosocial treatment on survival of patients with metastatic breast cancer, Lancet, 1989, 2 (8668), p. 888-891
27. Stone, J., Sood, R., Brink., D.: Behavioral and pharmacological therapies for late-life insomnia. A randomized controlled trial, JAMA, 1999, 281, No 11, p. 991-999.